Date | Analyst | Company | Last | Target | Call | Valuation |
10/25/22 | Credit Suisse | ART | 0.875 | 0.97 | Buy | |
10/25/22 | DBS Vickers | Capitaland Integrated Commercial Trust | 1.74 | 2.2 | Buy | |
10/25/22 | OCBC | Capitaland Integrated Commercial Trust | 1.74 | 2.15 | Buy | |
10/25/22 | DMG & Partners | Capitaland Integrated Commercial Trust | 1.74 | 2 | Buy | DDM |
10/25/22 | Credit Suisse | Capitaland Integrated Commercial Trust | 1.74 | 2.31 | Buy | |
10/25/22 | Citi Research | Capitaland Integrated Commercial Trust | 1.74 | 2.35 | Buy | |
10/25/22 | UOB Kay Hian | DBS | 32.39 | 45.75 | Buy | GGM, PB1.94x FY23 |
10/25/22 | Lim & Tan | DBS | 32.39 | 39.5 | Accumulate | |
10/25/22 | DBS Vickers | IHH Healthcare | 1.79 | 2.37 | Buy | Ringgit $7.90 target price |
10/25/22 | Credit Suisse | Mapletree Commercial | 1.55 | 2.05 | Buy | |
10/25/22 | DBS Vickers | OCBC | 11.53 | 16.82 | Buy | GGM, PB1.34x FY23 |
10/25/22 | CIMB | Raffles Medical | 1.21 | 1.6 | Add |
Wednesday, October 26, 2022
Stock calls for 25 october 2022
Sunday, October 23, 2022
Is co-exist policy or zero covid policy better? The truth is out!
Co-Exist Policy (US) | Zero Covid Policy (China) | Winner | |
Infection (Million): | 96.9 | 1.02 | Zero Covid Policy (China) |
Total death (‘000): | 1006 | 5.2 | Zero Covid Policy (China) |
7-day ave case: | 35287 | 982 | Zero Covid Policy (China) |
7-day ave death: | 377 | No death after May 2022 | Zero Covid Policy (China) |
Long covid case (Million): | 24 | Negligible | Zero Covid Policy (China) |
Incapacitated 80% (Million): | 19.2 | Negligible | Zero Covid Policy (China) |
Long covid unemployment: | 4 | Negligible | Zero Covid Policy (China) |
Long covid wage loss (Billion): | 170 | Negligible | Zero Covid Policy (China) |
GDP Q1: | -1.60% | 4.80% | Zero Covid Policy (China) |
GDP Q2: | -0.60% | 0.40% | Zero Covid Policy (China) |
Saturday, October 22, 2022
Mandarin Oriental - Stock calls
Date | Analyst | Company | Last | Target | Call | Valuation |
08/29/22 | DBS Vickers | Mandarin Oriental | 2.02 | 2.3 | Buy | Sum of parts |
Livingstone - Stock calls
Date | Analyst | Company | Last | Target | Call | Valuation |
02/04/22 | SAC Capital | Livingstone | 0.147 | 0.168 | Hold | DCF |
Lian Beng - Stock calls
Date | Analyst | Company | Last | Target | Call | Valuation |
06/15/21 | Lim & Tan | Lian Beng | 0.485 | 0 | Reject offer | offer price $0.50 |
Stock calls for 21 october 2022
Date | Analyst | Company | Last | Target | Call | Valuation |
10/21/22 | CIMB | Aztech | 0.74 | 0.96 | Add | PER7.7x FY23 |
10/21/22 | Lim & Tan | Ireit | 0.485 | 0.69 | Accumulate | |
10/21/22 | DBS Vickers | Keppel Infrastructure | 0.525 | 0.63 | Buy | |
10/21/22 | UOB Kay Hian | Parkway Life | 3.81 | 4.13 | Hold | DDM |
10/21/22 | DBS Vickers | Raffles Medical | 1.23 | 1.63 | Buy | |
10/21/22 | CIMB | Thai Beverage | 0.57 | 0.88 | Add |
Friday, October 21, 2022
LHN - Stock calls
Date | Analyst | Company | Last | Target | Call | Valuation |
06/07/21 | Phillip | LHN | 0.295 | 0.54 | Buy | PER9.5x FY21 |
09/28/21 | Amfrasers | LHN | 0.315 | 0.49 | Outperform | PER6x FY22 |
11/29/21 | Lim & Tan | LHN | 0.365 | 0 | Take Profit | |
12/01/21 | Phillip | LHN | 0.335 | 0.49 | Buy | PER7x FY22 |
12/23/21 | Amfrasers | LHN | 0.3 | 0.44 | Outperform | |
04/25/22 | Phillip | LHN | 0.34 | 0.49 | Buy | |
05/03/22 | Phillip | LHN | 0.31 | 0.51 | Buy | |
06/03/22 | CIMB | LHN | 0.143 | 0.22 | Add |